Microbiome's effect on white matter in autism

Area of Science:

• Neuroscience
• Microbiology
• Developmental Psychology

Background:

• Autism spectrum disorder (ASD) presents with social communication deficits and repetitive behaviors.
• Individuals with ASD exhibit distinct white matter development patterns, including hypermyelination followed by reduced myelination.
• Core ASD symptoms correlate with white matter dysregulation detected via diffusion tensor imaging (DTI).

Purpose of the Study:

• To explore the relationship between gut microbiome alterations and white matter development in ASD.
• To investigate potential therapeutic strategies targeting the gut-brain axis for ASD management.

Main Methods:

• Analysis of neuroimaging data, specifically diffusion tensor imaging (DTI), to assess white matter integrity.
• Assessment of gut microbiome diversity and composition, focusing on beneficial bacteria like Bifidobacterium and Lactobacillus.
• Review of emerging mechanistic evidence linking gut metabolites and neuroinflammation to brain development.

Main Results:

• Decreased gut microbiome diversity, particularly reductions in Bifidobacterium and Lactobacillus, correlates with ASD symptom severity.
• White matter dysregulation in ASD is significantly associated with core symptom impairments.
• Bidirectional interactions between the gut microbiome and white matter development are suggested through metabolites and neuroinflammation.

Conclusions:

• The gut microbiome plays a potential role in white matter development and ASD pathophysiology.
• Targeting the gut-brain axis presents a promising avenue for novel therapeutic interventions in ASD.
• Integrating gut physiology and brain imaging data is crucial for advancing ASD management.